Search Results (312)

This study examines the hydro-sedimentological–radioecological controls governing the distribution of natural (K-40, Ra-226, Th-232) and anthropogenic (Cs-137) radionuclides in surface sediments of the western Black Sea shelf. Activity concentrations were determined by high-resolution gamma spectrometry, and radiological indices—including radium equivalent activity (Ra_eq), external hazard index (H_ex), and annual effective dose (AED)—were calculated to evaluate environmental safety. All indices remained well below internationally accepted thresholds, confirming the absence of radiological hazard in both coastal and offshore settings. Strong correlations between Ra-226 and Th-232 indicate dominant lithogenic control of natural radionuclides, whereas Cs-137 exhibits geochemical decoupling consistent with its behavior. A significant relationship between the fine-grained sediment fraction (<63 µm) and Cs-137 activity highlights the grain size effect, with offshore depositional zones acting as sediment-focusing areas where Cs-137 and excess Pb-210 co-accumulate under low-energy hydrodynamic conditions. Despite localized offshore enrichment, dose contribution analysis shows that natural radionuclides dominate the absorbed-dose budget, while Cs-137 contributes only marginally. Spatial predictive modeling using Artificial Neural Networks, validated under a Spatial Leave-One-Group-Out framework, yielded moderate generalization capacity (R² = 0.61 for Ra-226; R² = 0.41 for Cs-137), reflecting smoother spatial gradients of lithogenic radionuclides than heterogeneous radiocesium deposition. Furthermore, Machine Learning algorithms provided significant analytical value: a Random Forest (RF) model successfully classified environments (nearshore/shelf/depositional basin) based on distinct radionuclide signatures. At the same time, an optimized Artificial Neural Network (ANN-GA) enabled the nonlinear reconstruction of radiometric–granulometric patterns to identify local anomalies. The results show that radionuclide distributions are primarily structured by sediment provenance, grain size sorting, and hydrodynamic energy gradients rather than ongoing anthropogenic inputs. Full article

Groundwater used for drinking in settlements located near decommissioned uranium mining facilities may contain elevated naturally occurring radioactive materials, posing long-term public-health concerns. The purpose of this study was to evaluate the radiological quality of groundwater used for drinking in the Saumalkol settlement by applying gross alpha–beta screening and isotope-specific analysis of ²²⁶Ra and ²²⁸Ra to identify the main contributors to groundwater radioactivity and estimate the associated radiation dose from water consumption. Groundwater samples were analyzed using gross alpha–beta screening and isotope-specific determination of ²²⁶Ra and ²²⁸Ra by radiochemical separation and low-background counting, and ingestion doses were estimated using international dose coefficients. Gross alpha activity averaged 2.26 ± 0.96 Bq/L, with most samples exceeding the WHO screening value of 0.5 Bq/L, while gross beta activity averaged 0.65 ± 0.17 Bq/L. Mean activity concentrations of ²²⁶Ra and ²²⁸Ra were 0.17 ± 0.03 Bq/L and 1.47 ± 0.9 Bq/L, respectively, with significantly higher ²²⁸Ra in deep boreholes and a systematic predominance of ²²⁸Ra over ²²⁶Ra (p < 0.05), indicating a thorium-controlled geochemical signature in fractured crystalline aquifers. The estimated annual committed effective ingestion dose from radium isotopes was 0.46 mSv, exceeding the reference level of 0.1 mSv for drinking-water exposure. These findings demonstrate that groundwater radioactivity in Saumalkol is dominated by radium from the thorium series and highlight the need for sustained radionuclide-specific monitoring and targeted water management strategies in uranium-affected regions. Full article

Ultraviolet (UV) radiation induces DNA damage and oxidative stress in melanocytes, shaping pigmentation phenotypes and elevating photocarcinogenesis risk. Human models that capture donor-linked genetic determinants of UV sensitivity remain limited. Here, we establish a genotype-informed UV response model using induced pluripotent stem cell (iPSC)-derived melanocytes from donors carrying defined MC1R variants. Differentiated cells recapitulated melanocytic morphology, marker expression, and pigmentation consistent with donor sun-sensitivity traits. Following narrowband UVB exposure, melanocyte lines with higher UV sensitivity showed reduced survival, prolonged checkpoint activation, and CPD-associated DNA damage signaling dynamics. Mechanistic analysis suggests that the interferon-regulated GTPase MX2 is associated with amplification of UV-induced p53 and p38 activation while promoting apoptosis independently of AKT. These findings support MX2 as a physiological enhancer of DNA damage signaling in normal melanocytes, distinct from its interferon-mediated role in melanoma. Our study provides a human-relevant platform linking pigmentation genotype to UV resilience and supports iPSC-derived systems as new approach methodologies (NAMs) for mechanistic and translational phototoxicology. Full article

Rationale: Radium-223 dichloride (²²³RaCl₂) is an FDA-approved alpha-emitting radiopharmaceutical that targets bone metastases in metastatic castration-resistant prostate cancer (mCRPC). This study investigates the therapeutic and immunological effects of combining ²²³RaCl₂ with immune checkpoint inhibitors (ICIs) in a clinically relevant, immunocompetent murine model of prostate cancer bone metastasis. Methods: Luciferase-expressing MyC-CaP prostate cancer cells were implanted intratibially into FVB mice to establish bone metastases. Mice were treated with escalating doses of ²²³RaCl₂ (0.04–0.27 µCi) alone or a single dose combined with anti-CTLA-4 and anti-PD-L1 ICIs. Tumor growth was monitored using bioluminescence imaging. Micro-CT, alpha camera imaging, histology, and qPCR were used to assess bone remodeling, radiopharmaceutical distribution, immune infiltration, and gene expression. Ex vivo biodistribution and blood analyses quantified tissue uptake and toxicity. Results: Escalating doses of ²²³RaCl₂ did not significantly inhibit tumor growth or improve survival. Biodistribution and imaging showed preferential localization of ²²³RaCl₂ to tumor-adjacent bone, with minimal signal in isolated tumor tissue. Immunohistochemistry revealed increased CD4⁺ and CD8α⁺ T-cell infiltration in regions of high γH2AX expression, indicating localized immune modulation. However, combination therapy with ICIs did not enhance tumor control or immune infiltration beyond monotherapy. qPCR demonstrated significant upregulation of Mhc1 only in the combination group, suggesting localized immune activation. Toxicity profiles remained acceptable. Conclusions: ²²³RaCl₂ localizes primarily to bone surfaces, limiting direct cytotoxic and immunomodulatory effects within the tumor microenvironment. While combination with ICIs did not improve efficacy, these findings provide a platform for studying spatial dose distribution and support future development of tumor-targeted alpha therapies to potentiate immunotherapy in mCRPC. Full article

Radiopharmaceutical therapy (RPT) has emerged as a transformative modality in oncology, particularly for patients with metastatic or inoperable tumors. By leveraging molecularly targeted carriers conjugated to cytotoxic radionuclides, RPT enables precise delivery of ionizing radiation to tumor sites while minimizing off-target effects. Central to this approach are alpha (α) and beta (β) particle-emitting radionuclides. This review aims to provide a comprehensive overview of all clinically relevant alpha and beta emitters and incorporates the most recent advances from 2017–2025, offering a comprehensive and up-to-date perspective. Alpha and beta emitters hold significant promises for the future, especially in nuclear medicine, energy, and environmental monitoring. Medically, these emitters are at the forefront of targeted radiotherapy, offering new hope for cancer treatment. Alpha emitters such as Actinium-225 and Radium-223 are gaining attention for their high linear energy transfer, which allows them to effectively kill cancer cells while minimizing damage to surrounding healthy tissues. Beta emitters, including Lutetium-177 and Iodine-131, are already widely used for treating thyroid cancer, neuroendocrine tumors, and prostate cancer. They offer a longer range in tissue penetration than alpha particles, making them suitable for larger or more diffuse tumors. Alpha and beta emitters hold tremendous promise in targeted radiotherapy. However, current research is limited by an incomplete understanding of resistance pathways, insufficient long-term safety and efficacy data, and underdeveloped personalized treatment frameworks. As production technologies improve and safety protocols advance, these emitters will likely play an even more prominent role in both health care and scientific innovation. Full article

This study investigates the gel characteristics of alkali-activated materials (AAMs) synthesized using wood ash (WA), and metakaolin (MK) as solid precursors. The research explores the influence of precursor type and sodium hydroxide (NaOH) concentrations in the alkali activator solution on the resulting physicochemical, microstructural, mechanical, and radiological properties of gels. The alkaline activators were prepared by mixing sodium hydroxide solutions (6 M and 12 M) with a sodium silicate (water glass) solution at a volume ratio of 1.5. The physicochemical characteristics of raw materials and AAMs were thoroughly analyzed using X-ray fluorescence (XRF), Diffuse Reflectance Infrared Fourier Transform (DRIFT) spectroscopy, X-ray diffraction (XRD), and scanning electron microscopy (SEM) with EDS elemental mapping. FTIR analysis confirmed the formation of an amorphous gels geopolymer network. XRD revealed the presence of characteristic crystalline phases (quartz, calcite) within an amorphous matrix. Mechanical properties, such as compressive strength, depended on precursor type and alkali molarity: metakaolin (12 M) reached ~14 MPa, while wood ash showed ~4 MPa (6 M) and ~0.5 MPa (12 M) due to high CaO, low Si and Al, and unfavorable SiO₂/Al₂O₃ (5.71) and Na₂O/Al₂O₃ (3.19) ratios. Furthermore, this research estimates radiological doses by quantifying radionuclide content via gamma-spectrometry. Alkali activation significantly reduced radiological hazard parameters, with radium equivalent activity (Ra_eq) decreasing to 238.0 Bq/kg and the external hazard index (H_ex) to 0.643 for A₁₂MK, while the annual effective dose rate for A₁₂WA was only 0.265 nSv/y-all values remaining well below the recommended safety limit of 370 Bq/kg (≤1 mSv/y). The decrease in activity concentration index (I_γ), Ra_eq, and H_ex with increasing NaOH concentration indicates effective radionuclide immobilization within the geopolymer matrix, confirming the suitability of these alkali-activated materials for safe use in construction from a radiation protection perspective. Full article

This study assessed natural radioactivity values and corresponding radiological hazards in gypsum samples collected from the investigated area. The geologic context mainly includes tertiary and quaternary sedimentary formations with gypsum horizons of Early Messinian age, interbedded with layers of limestone and marl. A total of thirty-five gypsum samples were collected and analyzed for the ²³⁸U, ²³²Th, and ⁴⁰K activity concentration using High-Purity Germanium (HPGe) gamma-ray spectrometry. The mean activity concentrations for the gypsums are reported at 73 ± 87 Bq kg⁻¹, 14 ± 17 Bq kg⁻¹, and 35 ± 201 Bq kg⁻¹ for ²³⁸U, ²³²Th, and ⁴⁰K, respectively. Several related radiological hazard indices were estimated from the various activity concentrations, including radium equivalent activity (Ra_eq) and absorbed dose rate (D_air). All gypsum analyzed fell below international safety limits for radiological risk, as evidenced by the observed radium equivalent activity (Raeq), with a maximum value of 456 Bq kg⁻¹, and the total annual effective dose (AED) values from 0.09 to 1.26 mSv y⁻¹ remaining between these two values. The results indicate the levels of radioactive hazards of the gypsum samples were generally below global safety standards, but individual samples (i.e., S17, S20, S24, S26, S30, S35) exceeded one or more of the hazard indices. Statistical assessment of the samples, with respect to their radiological hazard and natural radioactivity, was also undertaken as a way of seeking further insights into their relationships, productivity, and characteristics. This included Pearson correlation, hierarchical cluster analysis (HCA) and principal component analysis (PCA). The evidence suggests that for the gypsums, ²³⁸U was the greatest contributor to radiological hazards, influencing all hazard indices. Full article

This study is carried out to investigate the radiological characteristics and mineralogical controls of natural radioisotopes (²³⁸U, ²²⁶Ra, ²³²Th, and ⁴⁰K) in granitic pegmatites from Abu Zawal Area (AZA) in the Eastern Desert of Egypt. The analyzed pegmatites, containing thorite, zircon, monazite, ferrocolumbite, and fergusonite, exhibit exceptionally high radioactivity concentrations of ²³⁸U ≤ 568; ²³²Th ≤ 674; ²²⁶Ra ≤ 170 (Bq kg⁻¹), significantly exceeding the world average permissible limits (35, 30, 30, and 400 Bq kg⁻¹ for ²³⁸U, ²²⁶Ra, ²³²Th, and ⁴⁰K, respectively). Comprehensive radiological assessment reveals severely elevated radiological impact associated with Ra_eq ≤ 1243 (Bq kg⁻¹) and hazard indices (H_ex≤ 3.36; ELCR ≤ 12.2 × 10⁻³) surpassing international safety thresholds (H_ex ≤ 1; ELCR ≤ 1 × 10⁻³). The observed disequilibrium between ²³⁸U and ²²⁶Ra (with ²²⁶Ra activities approximately half those of ²³⁸U) is attributed to the geochemical mobility of radium and potential selective leaching during late-stage hydrothermal alteration, while the overall enrichment of the uranium series over the thorium series is linked to the predominance of uranium-bearing minerals like zircon and fergusonite in these pegmatites. Mineralogical analysis demonstrates distinct radiation patterns: thorite and monazite dominate Th-derived gamma radiation and radon/thoron exhalation, while zircon and fergusonite control U enrichment and decay chain disequilibrium. Notably, nominally low-activity minerals like ferrocolumbite contribute to localized radiation hotspots through U/Th co-concentrations. The calculated absorbed dose rates ranged from 182 to 978 (nGy h⁻¹) and annual effective doses show extreme spatial variability correlated with Th-rich mineral assemblages. Full article

Background: CD37, an antigen highly expressed in B-cell malignancies, served as the target in the LYMRIT-37-01 Part B (PARADIGME) and Part C studies employing a single intravenous injection of the radioimmunoconjugate ¹⁷⁷Lu–lilotomab satetraxetan (Betalutin^®). Methods: Patients with follicular lymphoma (FL), grades I–IIIa, who had received at least two previous lines of therapy and were refractory to at least one previous regimen with rituximab or an anti-CD20 agent, were included. They were randomized to receive either a 40 mg lilotomab pretreatment and an activity dosage of 15 MBq/kg Betalutin (“40/15” regimen) or 100 mg/m² of lilotomab and 20 MBq/kg of Betalutin (“100/20” regimen). In total, 109 patients were enrolled and received Betalutin, 72 of whom received the 40/15 regimen and 28 received the 100/20 regimen. An additional heavily pretreated “special population” of nine patients received 40/12.5 (i.e., a reduced Betalutin dosage) due to low platelets and/or a previous autologous stem cell transplant. Part C was a small expansion cohort of four patients, all receiving the 40/15 regimen, and was designed to obtain supplementary pharmacokinetic data. Results: The efficacy analysis set comprised a total of 100 patients from the PARADIGME study. The overall response rates were 38.9% and 32.1%, and the complete response rates were 20.8% and 14.3% in the 40/15 and 100/20 groups, respectively. Correspondingly, the median response durations were 8.5 months and 3.4 months in the two groups. Hence, increasing the Betalutin activity dose by using the stronger protective CD37 pre-dosing (“100/20”) did not improve the therapeutic benefit. The most common grade ≥ 3 adverse events were hematologic, including neutropenia (11.5%) and thrombocytopenia (8.0%), with nadirs occurring around weeks 5–7 and recovery by week 11. Conclusions: A single-dose administration of Betalutin had a mild toxicity profile with a clinically relevant response rate. It represents a viable treatment alternative in FL patients who are not suitable for more toxic and long-lasting treatments. Trial Registration: This trial was registered at clinicaltrials.gov under #NCT 01796171. Full article

Background: Radspherin^® is a novel α-emitting radiopharmaceutical administered intraperitoneally following complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) for peritoneal metastases. It delivers short-range radiation aimed at eliminating residual microscopic disease. This qualitative study explored how participants with colorectal cancer experienced participating in an early-phase clinical trial involving CRS-HIPEC followed by Radspherin^®. Materials and Methods: Semi-structured interviews were conducted with ten participants enrolled in a phase 1/2a trial involving CRS-HIPEC and intraperitoneal Radspherin^®. The analysis was guided by a phenomenological and interpretive approach using reflexive thematic analysis. Results: Participants expressed a strong sense of motivation and hope tied specifically to receiving Radspherin^®, which they perceived as an opportunity to improve their prognosis. Many also viewed participation as a contribution to future cancer research. None attributed complications or side effects to Radspherin^®. Clear and supportive verbal communication from healthcare professionals was highly valued, while the written information was described as overwhelming. Despite fears of recurrence, most participants remained optimistic about regaining a meaningful life. While experiences with Radspherin^® were largely positive, participants also described pain, fatigue, and prolonged recovery related to CRS-HIPEC, including ongoing functional and psychosocial challenges. Conclusions: Participants associated Radspherin^® with hope and a therapeutic benefit but did not link it to their adverse events. Their willingness to participate in experimental treatment was shaped by trust in clinicians, clear communication, and a desire for extended survival. However, the burden of CRS-HIPEC-related side effects underscores the importance of tailored follow-up and support. Full article

This study presents an integrated geological and environmental radiological analysis of basaltic volcanic rocks, which have been characterized by their suitability and potential for risk when used as construction materials. A total of thirty-five representative basaltic samples from the environment of studied area, located in the Northern Eastern Desert of Egypt, were utilized for this study. The rocks were then analyzed by means of HPGe high-resolution gamma-ray spectrometry methods. The petrographic studies show that the basalt samples were composed mostly of three main minerals: plagioclase, olivine, and pyroxene. In addition, these rocks have a significant degree of secondary alteration products, including sericite, epidote, and zoethite. For uranium-238 (²³⁸U), thorium-232 (²³²Th), and potassium-40 (⁴⁰K), the average activity concentration measured 53 ± 20 Bq kg⁻¹, 54 ± 14 Bq kg⁻¹, and 1178 ± 269 Bq kg⁻¹, respectively. Using the current global reference limits, all the measured values are above acceptable levels for the radionuclides ²³⁸U, ²³²Th, and ⁴⁰K. The radiological indices calculated for each of the basalt volcanic samples measured radium equivalent activity (Ra_eq = 221 Bq kg⁻¹), external hazard index (H_ex = 0.60), internal hazard index (H_in = 0.74), gamma index (Iγ = 0.84), and annual effective dose (AED = 0.52 mSv y⁻¹) indicate that the radiological hazard values of these samples are acceptable, unlike several samples, where values are near or exceed the accepted standards for indoor hazards. The most significant finding of this study reveals that the major contributions in the environment from radiological risk can be attributed to radionuclides ²³⁸U and ⁴⁰K based on correlation analysis, hierarchical clustering, and PCA analyses, and this study establishes the first multivariate perspective of how radiogenic materials controlled by the environment can affect basaltic rocks. Therefore, this study creates an important baseline for future environmental monitoring and states that caution is warranted when using basalt as a finished material for constructed environments, and for using basaltic products as raw materials in indoor environments. Full article

Background: Carriers of a pathogenic variant (PV) in BRCA1 face a high risk of breast cancer. This study estimated the risk of developing breast cancer according to mutation type and location. Methods: BRCA1 carriers with no personal history of breast cancer or bilateral mastectomy were included. Detailed information on clinical and family history was collected by questionnaire. Survival analysis was used to estimate 15-year cumulative risk according to PV type and location. Results: A total of 3677 BRCA1 carriers were followed for a mean of 7.2 years (range 0.1–15.0 years); 481 incident breast cancers were documented. Overall, the 15-year cumulative incidence was 25%. Risk estimates varied by exon, ranging from 9% (exon 21) to 19% (exon 12) to 36% (exon 15); however, strata were small. Carriers of four founder mutations common in Eastern Europe (c.5263_5264insC, c.181T > G, c.66_67delAG and c.4034delA) experienced a lower-than-expected cancer risk (15.9–24.4%) compared to other PVs (28.8%) (p = 0.02). Conclusions: Although our data suggests some variability in penetrance based on specific BRCA1 PV, this was based on a large number of founder mutations. Breast cancer management strategies should continue to be based on comprehensive risk assessment. Full article

Prostate cancer (PCa) remains one of the most prevalent malignancies among men worldwide and continues to pose significant therapeutic challenges, especially in its metastatic and castration-resistant forms. Over the past two decades, the treatment paradigm has evolved from monotherapy with androgen deprivation therapy (ADT) to a multifaceted approach integrating chemotherapy, androgen receptor axis-targeted therapies (ARATs), radiopharmaceuticals, and precision medicine. This review explores the molecular underpinnings of PCa, including genetic and epigenetic alterations such as BRCA1/2, TP53, and PTEN mutations, and their role in disease progression and treatment resistance. We detail the evidence supporting the integration of systemic agents like abiraterone, enzalutamide, and darolutamide into both hormone-sensitive and castration-resistant settings. Furthermore, we highlight the expanding role of radioligand therapies, including radium-223 and Lutetium-177-labeled PSMA-617 (Lu-PSMA-617), as well as the growing impact of PARP inhibitors in genomically selected patients. The emergence of theranostic strategies and next-generation sequencing has paved the way for personalized treatment algorithms, moving toward a truly precision oncology model in PCa. This comprehensive review synthesizes current therapeutic strategies, clinical trial evidence, and future directions aimed at optimizing outcomes and quality of life for patients with advanced prostate cancer. Full article

This review comprehensively assesses the clinical applications and future potential of alpha-emitting radionuclides available for targeted alpha-particle therapy (TAT) in cancer treatment. The approval of radium-223 therapy in 2013 marked a significant advancement in alpha-emitting therapeutic radiopharmaceuticals, which are primarily used in treatment of prostate cancer. The EU SECURE project was introduced as a major initiative to enhance the sustainability and safety of medical alpha-emitting radionuclides production in Europe. This literature review was conducted by a multidisciplinary team on selected radionuclides, including actinium-225, bismuth-213, astatine-211, lead-212, terbium-149, radium-223 and thorium-227. These were selected based on their clinical significance, as identified in the EU PRISMAP project and subsequent literature searches. The review process involved searching major databases using specific keywords related to alpha-emitter therapy and was limited to articles in English. For each selected radionuclide, the physical characteristics, the radiochemistry, and the pre-clinical and clinical studies are explored. Actinium-225 is the most widely studied alpha emitter, with several preclinical and clinical studies on prostate cancer and neuroendocrine tumours. Other types of tumours (such as glioblastoma) still require preclinical and clinical development. Bismuth-213 bound to antibodies, peptides and nanobodies has shown optimal results in preclinical and clinical studies, with increased median survival and no significant toxicity. Astatine-211 differs from most other α-emitters relevant to TAT, since it yields one α-particle per decay. This offers certain translational advantages, including the simplification of radiation dosimetry calculations and quality control (QC). Lead-212 has the advantage of being an in situ generator with likely widespread availability. Although clinical data are limited, the findings are promising at this stage. The unconventional production of Terbium-149 is the primary reason it has not yet progressed to clinical trials. Overcoming this production obstacle would allow more detailed preclinical investigations. Optimal results with Thorium-227-labelled agents have been observed in preclinical studies, including delays in cellular growth, multiple double-strand breaks and complete regression. Intermediate phase I trial results have also been reported, demonstrating safety and tolerability, as well as an objective response rate of 25%.: The results highlight the advantages of alpha particles in targeting cancer cells with minimal radiation to normal tissue, emphasising the need for high specificity and stability in delivery mechanisms, as well as suggesting that the full clinical potential of alpha particle therapy remains unexplored. Theranostic approach and dosimetric evaluations still represent relevant challenges. Full article

Groundwater quality is a key factor and a critical determinant of public health, agriculture, and socio-economic development, particularly in regions where private wells and mineral springs constitute the primary water sources. This study presents an integrated hydrochemical, radiological, and toxicological assessment of groundwater in the Sângeorz-Băi area, Romania, a spa region where mineral waters hold both therapeutic and economic significance. Samples from mineral springs, the municipal supply system, and private wells were analyzed to evaluate compliance with national and international standards and to assess their suitability for drinking, therapeutic, and agricultural purposes. The results reveal distinct hydrochemical contrasts between sources. Mineral springs are characterized by elevated salinity, hardness, and Na–HCO₃ facies, whereas the municipal network and private wells are dominated by Ca–HCO₃ facies. More than half of the private wells exceeded permissible limits for NO₃⁻, NO₂⁻, NH₄⁺, Pb, and Fe, with one well posing a significant nitrite-related health risk. Trace metal analysis indicated localized enrichment in Cu, Fe, and Pb. Radon and radium activities generally complied with regulations, although radium occasionally exceeded the more stringent WHO guidelines. Seasonal variation was minimal, reflecting stable groundwater chemistry. Health risk and irrigation assessments suggest that municipal supply water is largely safe for consumption, while private wells require targeted monitoring and mitigation. Despite elevated Na⁺ and Cl⁻, mineral springs retain therapeutic value under controlled use. This study provides a replicable framework for groundwater quality assessment in spa regions and offers critical insights for public health protection, sustainable tourism, and agricultural resilience. Full article